2 Canadian Millionaire-Maker Stocks Only Found on the NASDAQ

Two of Canada’s best-known millionaire-maker stocks can only be purchased on the NASDAQ.

| More on:
Dollar symbol and Canadian flag on keyboard

Image source: Getty Images

Canada has had its fair share of millionaire-maker stocks in the past. Some of these companies made people vast fortunes overnight. Two of these stocks, which still exist today, can only be found on the NASDAQ. However, these companies are still Canadian companies, both having their headquarters in the country. These two stocks are Lululemon Athletica (NASDAQ:LULU) and Tilray (NASDAQ:TLRY).

Lululemon Athletica

Lululemon has been a steady gainer for the past decade. The company effectively popularized the athleisure trend and has ridden that wave to enormous profitability and brand value.

The company is a Canadian company and is still headquartered in Vancouver, British Columbia. Although it previously had a Canadian stock listing, it de-listed from Canada in 2013 and went to a single listing on the NASDAQ at that time. The company cited additional administrative costs from maintaining dual listings as well as the thin trading volume of the Canadian-listed shares as the reasons for the de-listing.

Lululemon has 491 stores globally as of February 2020. This includes relatively new markets, such as China. The company has also invested heavily into its e-commerce platform, which has enabled it to thrive during and following the pandemic. It will be interesting to see how Lululemon integrates its recent acquisition, Mirror, into its broader strategy and vision.

The company’s shares could be had for under US$3 back in February 2009. Those who bought shares then and held on through July 2020 have made an eye-popping 8,860% return in that time.

LULU Chart


An early Canadian player in the medical cannabis sector, long before recreational cannabis became legal in October 2018, Tilray is a Canadian company and is headquartered in Nanaimo, British Columbia. The company never had a Canadian listing and opted to go public directly on the NASDAQ. This was a first for a Canadian cannabis company.

Tilray went public at $17 per share. Shortly after, it shot up to $300 per share, making many of its early owners multi-millionaires. However, like the rest of the cannabis industry, Tilray’s stock price came back down to earth. While the company doesn’t have a significant institutional investor, like some other companies, it has successfully struck major partnership deals with leading global brands including Anheuser-Busch InBev SA/NV.

TLRY Chart

It is important to note that this chart excludes the $300 intraday high that Tilray hit on September 19, 2018. A $300 price, which the company did hit, results in a 1,765% gain.

Is being on the NASDAQ better?

Tilray certainly took an unconventional path to the U.S. market. This is in stark contrast to the strategy taken by competitor Canopy Growth (TSX:WEED)(NYSE:CGC).

Canopy entered the public markets in its previous form as Tweed via a reverse takeover in 2014. It began its life on the TSX Venture. Eventually, the corporate name changed to Canopy Growth Corporation in 2015. Following early success in the capital markets, Canopy graduated to the TSX in 2016. Canopy listed on the NYSE in 2018. Recently, in 2019, it became the first cannabis company to join the S&P/TSX 60.

While Canopy was able to rack up similar gains as Tilray, it was over a longer period of time. Canopy simply did not see the meteoric rise that a stock like Tilray saw. U.S. listings alone don’t explain this, since Canopy listed in the U.S. in 2018, during the peak of Canadian cannabis frenzy. The combination of an IPO and being on the NASDAQ may have exposed Tilray to a greater number of investors at a pivotal time in its growth.

However, Tilray only listed a very small percentage of its outstanding shares when they went public. I believe that this scarcity of shares also played a large factor in the sudden share price spike. In short, being on the NASDAQ certainly wasn’t the only factor behind Tilray’s IPO success.


If you’re looking for Canadian stocks, be sure to keep your eyes peeled for opportunities on exchanges south of the border. Not considering these opportunities could mean that you miss out on the next big Canadian 100-bagger.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Lululemon Athletica. Fool contributor Kyle Walton has no position in the companies mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Here’s Why it’s Not Too Late to Buy Cronos Group Stock

The optimism about U.S. federal marijuana legalization and its anticipation are potent bullish triggers for the Canadian cannabis industry.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock Is on a Tear: Is it a Good Buy Now? 

Canopy Growth (TSX:WEED) stock surged by 80% from news out of the U.S., but is enough there without the news…

Read more »

Marijuana plant and cannabis oil bottles isolated
Cannabis Stocks

Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030

Quality cannabis stocks such as Green Thumb and Cresco Labs are positioned to deliver outsized gains to shareholders in 2024…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

The Big Mistake I See Cannabis Investors Making Over and Over Again

The news of marijuana slated to be legalized next year has seen a boost for cannabis investors, but they must…

Read more »

cup of cappuccino with a sad face
Cannabis Stocks

A TSX Stock I’d Avoid at All Costs

Despite posting a massive surge in share prices, Canopy Growth (TSX:WEED) is a stock you might be better off steering…

Read more »

edit Jars of marijuana
Cannabis Stocks

4 Reasons Canopy Growth Stock Looks Like a Screaming Buy

Canopy Growth (TSX:WEED) stock has a lot going for it lately, but there are still more hurdles ahead. Even so,…

Read more »